VAERS reports by lot

GSK Varicella/Shingles lot K4TG5: VAERS reports

33 VAERS reports list lot K4TG5 as a GSK Varicella/Shingles vaccine, received between 2023-02-09 and 2024-06-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
33
Reports
0%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction4448%
General / Systemic (non-local)1314%
Neurological910%
Allergic / Anaphylactic67%
Gastrointestinal55%
Dermatological (non-injection-site)55%
Musculoskeletal44%
Psychiatric / Neuropsychiatric33%
Cardiac / Cardiovascular11%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida6
Connecticut4
Iowa3
New York3
Massachusetts2
Pennsylvania2
Kansas1
Idaho1
Wisconsin1
Arizona1
Nevada1
Rhode Island1

Reports by month received

2023-023
2023-032
2023-045
2023-053
2023-066
2023-074
2023-092
2024-068

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.